(2021) Certolizumab-pegol/methotrexate. Reactions Weekly, 1872 (1) 125 doi:10.1007/s40278-021-02051-y
Reference Type | Journal (article/letter/editorial) | ||
---|---|---|---|
Title | Certolizumab-pegol/methotrexate | ||
Journal | Reactions Weekly | ||
Year | 2021 (September) | Volume | 1872 |
Issue | 1 | ||
Publisher | Springer Science and Business Media LLC | ||
DOI | doi:10.1007/s40278-021-02051-ySearch in ResearchGate | ||
Generate Citation Formats | |||
Mindat Ref. ID | 13794037 | Long-form Identifier | mindat:1:5:13794037:2 |
GUID | 0 | ||
Full Reference | (2021) Certolizumab-pegol/methotrexate. Reactions Weekly, 1872 (1) 125 doi:10.1007/s40278-021-02051-y | ||
Plain Text | (2021) Certolizumab-pegol/methotrexate. Reactions Weekly, 1872 (1) 125 doi:10.1007/s40278-021-02051-y | ||
In | (2021, September) Reactions Weekly Vol. 1872 (1) Springer Science and Business Media LLC |
See Also
These are possibly similar items as determined by title/reference text matching only.
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |